NIH Study Finds Antiviral Ineffective for Long COVID Symptoms

A clinical trial under the NIH's RECOVER initiative concluded that a common antiviral drug did not alleviate Long COVID symptoms over 25 days compared to a placebo. Published in *Lancet Infectious Diseases*, these findings suggest that alternative treatment strategies are necessary for managing persistent Long COVID. This outcome is significant for ongoing research into effective therapies for the condition.